Indivior Pharmaceuticals, Inc. (INDV) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | $262.00M | +589.5% |
| 2024 | $38.00M | +125.0% |
| 2023 | -$152.00M | -87.7% |
| 2022 | -$81.00M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | $262.00M | +589.5% |
| 2024 | $38.00M | +125.0% |
| 2023 | -$152.00M | -87.7% |
| 2022 | -$81.00M | — |